Direkt zum Inhalt
Merck

Upregulation of ALDH1B1 promotes tumor progression in osteosarcoma.

Oncotarget (2018-02-09)
Xin Wang, Yan Yu, Yuting He, Qiqing Cai, Songtao Gao, Weitao Yao, Zhiyong Liu, Zhichao Tian, Qicai Han, Weiwei Wang, Ranran Sun, Yonggang Luo, Chao Li
ZUSAMMENFASSUNG

Osteosarcoma (OS) is the most common primary malignant bone tumor in childhood and adolescence with poor prognosis. The mechanism underlying tumorigenesis and development of OS is largely unknown. ALDH1B1 has been reported to involve in many kinds of human cancers and functions as an oncogene, but the role of ALDH1B1 in OS has not been investigated comprehensively. In the present study, we aimed to examine clinical value and biological function of ALDH1B1 in OS. Firstly, we investigated the roles of ALDH1B1 on an OS tissue microarray (TMA) as well as two OS cohorts from GEO database. We found that ALDH1B1 was significantly up-regulated in OS tissues and was independently associated with poor prognosis. Moreover, ALDH1B1 silencing could suppress the proliferation, migration, invasion

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
MISSION® esiRNA, targeting human ALDH1B1